aluates Reports

$ 0.0

Automative

Global Acinetobacter Infections Treatment Market Research Report 2026

Published Date: 2026-02-06

Report Code: QYRE-Auto-L9

China Acinetobacter Infections Treatment Market Report Forecast 2021 2027

BUY CHAPTERS

Global Acinetobacter Infections Treatment Market Research Report 2026

Code: QYRE-Auto-L9

Report

2026-02-06

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Entasis Therapeutics

Roche

Adenium Biotech

Vaxdyn

Hsiri Therapeutics

Aridis Pharmaceuticals

LegoChem Biosciences

Atterx Biotherapeutics

Achaogen Inc

Peptilogics

Sealife PHARMA

Shionogi

Techulon

Tetraphase Pharmaceuticals

Acinetobacter Infections Treatment Market

The global Acinetobacter Infections Treatment market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.

Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.

Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.

In the American market, Major manufacturers include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, and Legochem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife Pharma, Shionogi, Techulon and Tetraphase Pharmaceuticals, among others. Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.

This report delivers a comprehensive overview of the global Acinetobacter Infections Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Acinetobacter Infections Treatment. The Acinetobacter Infections Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Acinetobacter Infections Treatment market comprehensively. Regional market sizes by Type, by Pipeline, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Acinetobacter Infections Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Pipeline, and by region.

Market Segmentation

Scope of Acinetobacter Infections Treatment Market Report

Report Metric	Details
Report Name	Acinetobacter Infections Treatment Market
Segment by Type	Sulbactam Carbapenems Aminoglycosides Polymyxins Tetracyclines Others
Segment by Pipeline	ETX2514 Nacubactam RG6080 Arenicin VXD-001 Small Molecule Antibiotic AR-401 mAB LCB01-0371 (PO) GN-4474 Antibacterial Antibody Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, LegoChem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife PHARMA, Shionogi, Techulon, Tetraphase Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Pipeline, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Acinetobacter Infections Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Pipeline, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

What is the market share of major companies in Acinetobacter Infections Treatment Market?

Ans: Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.

Who are the main players in the Acinetobacter Infections Treatment Market report?

Ans: The main players in the Acinetobacter Infections Treatment Market are Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, LegoChem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife PHARMA, Shionogi, Techulon, Tetraphase Pharmaceuticals

What are the Type segmentation covered in the Acinetobacter Infections Treatment Market report?

Ans: The Types covered in the Acinetobacter Infections Treatment Market report are Sulbactam, Carbapenems, Aminoglycosides, Polymyxins, Tetracyclines, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acinetobacter Infections Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Sulbactam

1.2.3 Carbapenems

1.2.4 Aminoglycosides

1.2.5 Polymyxins

1.2.6 Tetracyclines

1.2.7 Others

1.3 Market by Pipeline

1.3.1 Global Acinetobacter Infections Treatment Market Growth by Pipeline: 2021 vs 2025 vs 2032

1.3.2 ETX2514

1.3.3 Nacubactam RG6080

1.3.4 Arenicin

1.3.5 VXD-001

1.3.6 Small Molecule Antibiotic

1.3.7 AR-401 mAB

1.3.8 LCB01-0371 (PO)

1.3.9 GN-4474

1.3.10 Antibacterial Antibody

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acinetobacter Infections Treatment Market Perspective (2021–2032)

2.2 Global Acinetobacter Infections Treatment Growth Trends by Region

2.2.1 Global Acinetobacter Infections Treatment Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Acinetobacter Infections Treatment Historic Market Size by Region (2021–2026)

2.2.3 Acinetobacter Infections Treatment Forecasted Market Size by Region (2027–2032)

2.3 Acinetobacter Infections Treatment Market Dynamics

2.3.1 Acinetobacter Infections Treatment Industry Trends

2.3.2 Acinetobacter Infections Treatment Market Drivers

2.3.3 Acinetobacter Infections Treatment Market Challenges

2.3.4 Acinetobacter Infections Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Acinetobacter Infections Treatment Players by Revenue

3.1.1 Global Top Acinetobacter Infections Treatment Players by Revenue (2021–2026)

3.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Players (2021–2026)

3.2 Global Top Acinetobacter Infections Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Acinetobacter Infections Treatment Revenue

3.4 Global Acinetobacter Infections Treatment Market Concentration Ratio

3.4.1 Global Acinetobacter Infections Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acinetobacter Infections Treatment Revenue in 2025

3.5 Global Key Players of Acinetobacter Infections Treatment Head Offices and Areas Served

3.6 Global Key Players of Acinetobacter Infections Treatment, Products and Applications

3.7 Global Key Players of Acinetobacter Infections Treatment, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Acinetobacter Infections Treatment Breakdown Data by Type

4.1 Global Acinetobacter Infections Treatment Historic Market Size by Type (2021–2026)

4.2 Global Acinetobacter Infections Treatment Forecasted Market Size by Type (2027–2032)

5 Acinetobacter Infections Treatment Breakdown Data by Pipeline

5.1 Global Acinetobacter Infections Treatment Historic Market Size by Pipeline (2021–2026)

5.2 Global Acinetobacter Infections Treatment Forecasted Market Size by Pipeline (2027–2032)

6 North America

6.1 North America Acinetobacter Infections Treatment Market Size (2021–2032)

6.2 North America Acinetobacter Infections Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Acinetobacter Infections Treatment Market Size by Country (2021–2026)

6.4 North America Acinetobacter Infections Treatment Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Acinetobacter Infections Treatment Market Size (2021–2032)

7.2 Europe Acinetobacter Infections Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Acinetobacter Infections Treatment Market Size by Country (2021–2026)

7.4 Europe Acinetobacter Infections Treatment Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Acinetobacter Infections Treatment Market Size (2021–2032)

8.2 Asia-Pacific Acinetobacter Infections Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2021–2026)

8.4 Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Acinetobacter Infections Treatment Market Size (2021–2032)

9.2 Latin America Acinetobacter Infections Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Acinetobacter Infections Treatment Market Size by Country (2021–2026)

9.4 Latin America Acinetobacter Infections Treatment Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Acinetobacter Infections Treatment Market Size (2021–2032)

10.2 Middle East & Africa Acinetobacter Infections Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2021–2026)

10.4 Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Entasis Therapeutics

11.1.1 Entasis Therapeutics Company Details

11.1.2 Entasis Therapeutics Business Overview

11.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Introduction

11.1.4 Entasis Therapeutics Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.1.5 Entasis Therapeutics Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Acinetobacter Infections Treatment Introduction

11.2.4 Roche Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.2.5 Roche Recent Development

11.3 Adenium Biotech

11.3.1 Adenium Biotech Company Details

11.3.2 Adenium Biotech Business Overview

11.3.3 Adenium Biotech Acinetobacter Infections Treatment Introduction

11.3.4 Adenium Biotech Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.3.5 Adenium Biotech Recent Development

11.4 Vaxdyn

11.4.1 Vaxdyn Company Details

11.4.2 Vaxdyn Business Overview

11.4.3 Vaxdyn Acinetobacter Infections Treatment Introduction

11.4.4 Vaxdyn Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.4.5 Vaxdyn Recent Development

11.5 Hsiri Therapeutics

11.5.1 Hsiri Therapeutics Company Details

11.5.2 Hsiri Therapeutics Business Overview

11.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Introduction

11.5.4 Hsiri Therapeutics Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.5.5 Hsiri Therapeutics Recent Development

11.6 Aridis Pharmaceuticals

11.6.1 Aridis Pharmaceuticals Company Details

11.6.2 Aridis Pharmaceuticals Business Overview

11.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Introduction

11.6.4 Aridis Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.6.5 Aridis Pharmaceuticals Recent Development

11.7 LegoChem Biosciences

11.7.1 LegoChem Biosciences Company Details

11.7.2 LegoChem Biosciences Business Overview

11.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Introduction

11.7.4 LegoChem Biosciences Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.7.5 LegoChem Biosciences Recent Development

11.8 Atterx Biotherapeutics

11.8.1 Atterx Biotherapeutics Company Details

11.8.2 Atterx Biotherapeutics Business Overview

11.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Introduction

11.8.4 Atterx Biotherapeutics Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.8.5 Atterx Biotherapeutics Recent Development

11.9 Achaogen

11.9.1 Achaogen Company Details

11.9.2 Achaogen Business Overview

11.9.3 Achaogen Acinetobacter Infections Treatment Introduction

11.9.4 Achaogen Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.9.5 Achaogen Recent Development

11.10 Peptilogics

11.10.1 Peptilogics Company Details

11.10.2 Peptilogics Business Overview

11.10.3 Peptilogics Acinetobacter Infections Treatment Introduction

11.10.4 Peptilogics Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.10.5 Peptilogics Recent Development

11.11 Sealife PHARMA

11.11.1 Sealife PHARMA Company Details

11.11.2 Sealife PHARMA Business Overview

11.11.3 Sealife PHARMA Acinetobacter Infections Treatment Introduction

11.11.4 Sealife PHARMA Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.11.5 Sealife PHARMA Recent Development

11.12 Shionogi

11.12.1 Shionogi Company Details

11.12.2 Shionogi Business Overview

11.12.3 Shionogi Acinetobacter Infections Treatment Introduction

11.12.4 Shionogi Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.12.5 Shionogi Recent Development

11.13 Techulon

11.13.1 Techulon Company Details

11.13.2 Techulon Business Overview

11.13.3 Techulon Acinetobacter Infections Treatment Introduction

11.13.4 Techulon Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.13.5 Techulon Recent Development

11.14 Tetraphase Pharmaceuticals

11.14.1 Tetraphase Pharmaceuticals Company Details

11.14.2 Tetraphase Pharmaceuticals Business Overview

11.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Introduction

11.14.4 Tetraphase Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2021–2026)

11.14.5 Tetraphase Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Entasis Therapeutics

Roche

Adenium Biotech

Vaxdyn

Hsiri Therapeutics

Aridis Pharmaceuticals

LegoChem Biosciences

Atterx Biotherapeutics

Achaogen Inc

Peptilogics

Sealife PHARMA

Shionogi

Techulon

Tetraphase Pharmaceuticals

List of Tables

Table 1. Global Acinetobacter Infections Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Sulbactam

Table 3. Key Players of Carbapenems

Table 4. Key Players of Aminoglycosides

Table 5. Key Players of Polymyxins

Table 6. Key Players of Tetracyclines

Table 7. Key Players of Others

Table 8. Global Acinetobacter Infections Treatment Market Size Growth by Pipeline (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Acinetobacter Infections Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Acinetobacter Infections Treatment Market Size by Region (US$ Million), 2021–2026

Table 11. Global Acinetobacter Infections Treatment Market Share by Region (2021–2026)

Table 12. Global Acinetobacter Infections Treatment Forecasted Market Size by Region (US$ Million), 2027–2032

Table 13. Global Acinetobacter Infections Treatment Market Share by Region (2027–2032)

Table 14. Acinetobacter Infections Treatment Market Trends

Table 15. Acinetobacter Infections Treatment Market Drivers

Table 16. Acinetobacter Infections Treatment Market Challenges

Table 17. Acinetobacter Infections Treatment Market Restraints

Table 18. Global Acinetobacter Infections Treatment Revenue by Players (US$ Million), 2021–2026

Table 19. Global Acinetobacter Infections Treatment Market Share by Players (2021–2026)

Table 20. Global Top Acinetobacter Infections Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Acinetobacter Infections Treatment Revenue, 2025

Table 21. Ranking of Global Top Acinetobacter Infections Treatment Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Acinetobacter Infections Treatment Revenue (CR5 and HHI), 2021–2026

Table 23. Global Key Players of Acinetobacter Infections Treatment, Headquarters and Area Served

Table 24. Global Key Players of Acinetobacter Infections Treatment, Products and Applications

Table 25. Global Key Players of Acinetobacter Infections Treatment, Date of General Availability (GA)

Table 26. Mergers and Acquisitions, Expansion Plans

Table 27. Global Acinetobacter Infections Treatment Market Size by Type (US$ Million), 2021–2026

Table 28. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2021–2026)

Table 29. Global Acinetobacter Infections Treatment Forecasted Market Size by Type (US$ Million), 2027–2032

Table 30. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2027–2032)

Table 31. Global Acinetobacter Infections Treatment Market Size by Pipeline (US$ Million), 2021–2026

Table 32. Global Acinetobacter Infections Treatment Revenue Market Share by Pipeline (2021–2026)

Table 33. Global Acinetobacter Infections Treatment Forecasted Market Size by Pipeline (US$ Million), 2027–2032

Table 34. Global Acinetobacter Infections Treatment Revenue Market Share by Pipeline (2027–2032)

Table 35. North America Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. North America Acinetobacter Infections Treatment Market Size by Country (US$ Million), 2021–2026

Table 37. North America Acinetobacter Infections Treatment Market Size by Country (US$ Million), 2027–2032

Table 38. Europe Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 39. Europe Acinetobacter Infections Treatment Market Size by Country (US$ Million), 2021–2026

Table 40. Europe Acinetobacter Infections Treatment Market Size by Country (US$ Million), 2027–2032

Table 41. Asia-Pacific Acinetobacter Infections Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 42. Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (US$ Million), 2021–2026

Table 43. Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (US$ Million), 2027–2032

Table 44. Latin America Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Latin America Acinetobacter Infections Treatment Market Size by Country (US$ Million), 2021–2026

Table 46. Latin America Acinetobacter Infections Treatment Market Size by Country (US$ Million), 2027–2032

Table 47. Middle East & Africa Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 48. Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (US$ Million), 2021–2026

Table 49. Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (US$ Million), 2027–2032

Table 50. Entasis Therapeutics Company Details

Table 51. Entasis Therapeutics Business Overview

Table 52. Entasis Therapeutics Acinetobacter Infections Treatment Product

Table 53. Entasis Therapeutics Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 54. Entasis Therapeutics Recent Development

Table 55. Roche Company Details

Table 56. Roche Business Overview

Table 57. Roche Acinetobacter Infections Treatment Product

Table 58. Roche Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 59. Roche Recent Development

Table 60. Adenium Biotech Company Details

Table 61. Adenium Biotech Business Overview

Table 62. Adenium Biotech Acinetobacter Infections Treatment Product

Table 63. Adenium Biotech Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 64. Adenium Biotech Recent Development

Table 65. Vaxdyn Company Details

Table 66. Vaxdyn Business Overview

Table 67. Vaxdyn Acinetobacter Infections Treatment Product

Table 68. Vaxdyn Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 69. Vaxdyn Recent Development

Table 70. Hsiri Therapeutics Company Details

Table 71. Hsiri Therapeutics Business Overview

Table 72. Hsiri Therapeutics Acinetobacter Infections Treatment Product

Table 73. Hsiri Therapeutics Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 74. Hsiri Therapeutics Recent Development

Table 75. Aridis Pharmaceuticals Company Details

Table 76. Aridis Pharmaceuticals Business Overview

Table 77. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product

Table 78. Aridis Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 79. Aridis Pharmaceuticals Recent Development

Table 80. LegoChem Biosciences Company Details

Table 81. LegoChem Biosciences Business Overview

Table 82. LegoChem Biosciences Acinetobacter Infections Treatment Product

Table 83. LegoChem Biosciences Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 84. LegoChem Biosciences Recent Development

Table 85. Atterx Biotherapeutics Company Details

Table 86. Atterx Biotherapeutics Business Overview

Table 87. Atterx Biotherapeutics Acinetobacter Infections Treatment Product

Table 88. Atterx Biotherapeutics Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 89. Atterx Biotherapeutics Recent Development

Table 90. Achaogen Company Details

Table 91. Achaogen Business Overview

Table 92. Achaogen Acinetobacter Infections Treatment Product

Table 93. Achaogen Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 94. Achaogen Recent Development

Table 95. Peptilogics Company Details

Table 96. Peptilogics Business Overview

Table 97. Peptilogics Acinetobacter Infections Treatment Product

Table 98. Peptilogics Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 99. Peptilogics Recent Development

Table 100. Sealife PHARMA Company Details

Table 101. Sealife PHARMA Business Overview

Table 102. Sealife PHARMA Acinetobacter Infections Treatment Product

Table 103. Sealife PHARMA Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 104. Sealife PHARMA Recent Development

Table 105. Shionogi Company Details

Table 106. Shionogi Business Overview

Table 107. Shionogi Acinetobacter Infections Treatment Product

Table 108. Shionogi Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 109. Shionogi Recent Development

Table 110. Techulon Company Details

Table 111. Techulon Business Overview

Table 112. Techulon Acinetobacter Infections Treatment Product

Table 113. Techulon Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 114. Techulon Recent Development

Table 115. Tetraphase Pharmaceuticals Company Details

Table 116. Tetraphase Pharmaceuticals Business Overview

Table 117. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product

Table 118. Tetraphase Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (US$ Million), 2021–2026

Table 119. Tetraphase Pharmaceuticals Recent Development

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Authors List of This Report

List of Figures

Figure 1. Acinetobacter Infections Treatment Picture

Figure 2. Global Acinetobacter Infections Treatment Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Acinetobacter Infections Treatment Market Share by Type: 2025 vs 2032

Figure 4. Sulbactam Features

Figure 5. Carbapenems Features

Figure 6. Aminoglycosides Features

Figure 7. Polymyxins Features

Figure 8. Tetracyclines Features

Figure 9. Others Features

Figure 10. Global Acinetobacter Infections Treatment Market Size by Pipeline (US$ Million), 2021–2032

Figure 11. Global Acinetobacter Infections Treatment Market Share by Pipeline: 2025 vs 2032

Figure 12. ETX2514 Case Studies

Figure 13. Nacubactam RG6080 Case Studies

Figure 14. Arenicin Case Studies

Figure 15. VXD-001 Case Studies

Figure 16. Small Molecule Antibiotic Case Studies

Figure 17. AR-401 mAB Case Studies

Figure 18. LCB01-0371 (PO) Case Studies

Figure 19. GN-4474 Case Studies

Figure 20. Antibacterial Antibody Case Studies

Figure 21. Acinetobacter Infections Treatment Report Years Considered

Figure 22. Global Acinetobacter Infections Treatment Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 23. Global Acinetobacter Infections Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 24. Global Acinetobacter Infections Treatment Market Share by Region: 2025 vs 2032

Figure 25. Global Acinetobacter Infections Treatment Market Share by Players in 2025

Figure 26. Global Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 27. The Top 10 and 5 Players Market Share by Acinetobacter Infections Treatment Revenue in 2025

Figure 28. North America Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. North America Acinetobacter Infections Treatment Market Share by Country (2021–2032)

Figure 30. United States Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Canada Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Europe Acinetobacter Infections Treatment Market Share by Country (2021–2032)

Figure 34. Germany Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. France Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. U.K. Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Italy Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Russia Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Ireland Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Asia-Pacific Acinetobacter Infections Treatment Market Share by Region (2021–2032)

Figure 42. China Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Japan Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. South Korea Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Southeast Asia Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. India Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Australia & New Zealand Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Latin America Acinetobacter Infections Treatment Market Share by Country (2021–2032)

Figure 50. Mexico Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Brazil Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Middle East & Africa Acinetobacter Infections Treatment Market Share by Country (2021–2032)

Figure 54. Israel Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Saudi Arabia Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. UAE Acinetobacter Infections Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Entasis Therapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 58. Roche Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 59. Adenium Biotech Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 60. Vaxdyn Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 61. Hsiri Therapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 62. Aridis Pharmaceuticals Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 63. LegoChem Biosciences Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 64. Atterx Biotherapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 65. Achaogen Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 66. Peptilogics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 67. Sealife PHARMA Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 68. Shionogi Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 69. Techulon Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 70. Tetraphase Pharmaceuticals Revenue Growth Rate in Acinetobacter Infections Treatment Business (2021–2026)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Acetobacter Market Research Report 2025

Multidrug Resistant Bacteria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gram Negative lnfections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Perinatal Infections Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Aquaculture Bacterial Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inner Ear Infection Treatment Market Research Report 2025

Mycobacterium Abscessus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antimicrobial Technology Market Research Report 2024

Intra amniotic Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibiotic Resistance Market Insights Forecast to 2030

Global Staphylococcal Infection Drugs Market Insights Forecast to 2030

Dental Infection Prevention Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Eye Infection Drugs Market Insights Forecast to 2030

Global Mediastinitis Treatment Market Research Report 2024

Global Ceftriaxone Market Research Report 2025

Global Biological Treatment System Market Research Report 2025

Global Industrial Antimicrobial Agent Market Research Report 2025

Global Microbial Antibacterial Drugs Market Research Report 2024

Global Antimicrobial Barrier Dressing Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions